Tech Company M&A Transactions
InfaCare Pharmaceutical Acquisition
Headquartered in Trevose, InfaCare Pharmaceutical was acquired by Mallinckrodt. The acquisition price was $425 million.
Transaction Overview
Company Name
Acquired By
Announced On
9/26/2017
Transaction Type
M&A
Amount
$425,000,000
M&A Terms
Financial terms of the transaction include an upfront payment of $80 million, with additional payments of up to $345 million dependent on regulatory and sales milestones.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
8 Neshaminy Interplex 221
Trevose, PA 19053
USA
Trevose, PA 19053
USA
Phone
Website
Email Address
Overview
InfaCare Pharmaceutical Corporation is an emerging specialty pharmaceutical company focused on the acquisition, development and commercialization of products for neonates and older children and is led by John Post, President and CEO.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dan Burns
Chief Financial Officer
Ronald Goldfuss
Chief Medical Officer
Paul Blake
Browse more venture capital transactions:
Prev: 9/25/2017: Pixel Velocity venture capital transaction
Next: 9/26/2017: Jopwell venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs